Effect of ethanolic extract of Phyla nodiflora (Linn.) Greene against calculi producing diet induced urolithiasis

Indian Journal of Natural Products and Resources

Volumn 1, Issue 3, 2010, Pages 314-321

  Dodoala, Sujatha ^a   Diviti, Ranganayakulu ^a   Koganti, Bharathi ^b   Prasad, K V S R G ^b  

^a Sri Padmavathi School of Pharmacy   (India)

^b INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

Antiurolithiatic activity; Calcium oxalate; Calculi producing diet; Phyla nodiflora; Renal stones; Urolithiasis

Indexed keywords

PHYLA NODIFLORA; RATTUS;

EID: 79551632149     PISSN: 09760504     EISSN: 09760512     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. th Edn, WB Saunders and Co., Philadelphia, 2003, Vol.3, pp. 2661-2733.
2. Chopra RN, Nayar SL and Chopra IC, Glossary of Indian Medicinal Plants, Publications and Information Directorate, Council of Scientific and Industrial Research, New Delhi, 1956, pp.155-157.
3. Kirtikar KR and Basu BD, Indian Medicinal Plants, Publications and Information Directorate, CSIR. New Delhi, India, Reprint Edn, 1975, Vol-II, pp. 986-987.
4. Basu AK, Chakraborti P and Sanyal PK, Nodifloretin-A new flavone from Lippia nodiflora, J Indian Chem Soc, 1969, 46, 271-272.
5. Francisco A, Barbaran T, Harborne BJ and Self R, Twelve 6-oxygenated flavone sulphates from Lippia nodiflora and L. canescens, Phytochemistry, 1987, 26, 2281-2284.
6. Nair AGR, Ramesh P, Nagarajan S and Subramanian S, New flavone glycosides from Lippia nodifloria, Indian J Chem, 1973, 2, 1316-1317.
7. Forestieri AM, Monforte MT, Ragusa S, Trovato A and Lauk L, Antiinflammatory, analgesic and antipyretic activity in rodents of plant used in African medicine, Phytother Res, 1996, 10, 100-106.
8. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN and Mehrotra BN, Screening of plants for biological activity, Indian J Exp Biol, 1969, 7, 250-257.
9. Das AK, Choudhuri MSK, Selim MST and Ahmed F, Antiinflammatory and antinociceptive activities of Lippia nodiflora Linn., Pharmazie, 2004, 59, 329-330.
10. Sangita S, Rashmika Patel and Rajiv K, Study of phytochemical and diuretic potential of methanol and aqueous extracts of aerial parts of Phyla nodiflora Linn., Int J Pharm Pharmaceut Sci, 2009, 1, 85-91.
11. Selected topics in experimental pharmacology, by UK Sheth, NK Dadkar and Usha G Kamat (Eds), Kothari Book Depot, Bombay, 1972, pp. 124-128.
12. Crossland J, In: Lewis Pharmacology, Churchill Livingstone, New York, 1980, p. 137.
13. Sanjay Kumar, Sigmon D, Miller T, Carpenter B, Khan S, Malhotra R, Schied C and Menon M, A new model of nephrolithiasis involving tubular dysfunction/injury, J Urol, 1991, 146, 1384-1389.
14. Lorentz K, Improved determination of serum calcium with ortho cresolphthalein complexone, Clin Chim Acta, 1982, 126, 327-333.
15. Hodgkinson A and Williams A, An improved colorimetric procedure for urinary oxalate, Clin Chim Acta, 1972, 36, 127-132.
16. Niehaus WG Jr and Samuelsson B, Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation, Eur J Biochem, 1968, 6, 126-130.
17. Jollow D, Mitchell L, Zampaglione N and Gillete J, Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate, Pharmacology, 1974, 11, 151-169.
18. Hugo EB, Oxidoreductases acting on groups other than CHOH. Catalase, In: Methods in Enzymology, by SP Colowick, NO Kalpan and L Packer (Eds), London Academic Press, UK, 1984, Vol. 105, pp. 121-125.
19. 15N] nitrate in biological fluids, Anal Biochem, 1982, 126 (1), 131-138.
20. Blois MS, Antioxidant determination by the use of a stable free radical, Nature, 1958, 181, 1199-1200.
21. Khan SR, Animal models of kidney stone formation: An analysis, World J Urol, 1997, 15, 236-243.
22. Khan SR and Hackette RL, Membrane induced calcium oxalate crystal nucleation, Urol Res, 1988, 16, 185-189.
23. Chahwala SB and Harpur ES, Gentamycin - induced hypercalciuria in the rat, Acta Pharmacol Toxicol, 1983, 53, 358-364.
24. Baumann MJ, Stone Prevention: Why so little progress?, Urol Res, 1998, 26, 77-81.
25. Baskar R, Meenalakshmi Malini M, Varalakshmi P, Balakrishna K and Bhima Rao R, Effect of Lupeol isolated from Crataeva nurvala stem bark against free radicalinduced toxicity in experimental urolithiasis, Fitoterapia 1996, 67 (2), 121-125.
26. Finlayson B, Symposium on Renal lithiasis, 'Renal lithiasis in reviews', Urol Clin North Am, 1974, 10, 181-212.
27. Khan SR, Shevock PN and Hackett RL, Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis, J Urol, 1992, 147, 226-230.
28. Robertson WG and Peacock M, The course of idiopathic calcium disease: Hypercalciuria or Hyperoxaluaria, Nephron, 1980, 26, 105-110.
29. Borghi L, Meschi T, Amato F Briganti A, Novarini A and Giannini A, Urine volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5 year randomized prospective study, J Urol, 1996, 155, 839-843.
30. Prasad KVSRG, Abraham R, Bharathi K and Srinivasan KK, Evaluation of Homonia riparia Lour for antiurolithiatic activity in albino rats, Pharmaceut Biol, 1997, 35, 278-283.
31. Marshall RW and Robertson WG, Nanograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, Uric acid, Sodium acid urate, Clin Chim Acta, 1976, 72, 253.
32. Pak CYC, Renal stone disease, Martinus Nijhoff Publishing, Boston, 1987, pp. 120-128.
33. King JS Jr, Etiologic factors involved in urolithiasis, A review of recent research, J Urol, 1967, 97, 583-591.
34. Vermeulen CW, Ragins HD, Goetz R and Grove WJ, Experimental urolithiasis III. Prevention and dissolution of calculi by alteration of urinary pH, J Urol, 1951, 66, 24-28.
35. Singh CM and Sachin SS, Management of urolithiasis by herbal drugs, J Nepal Pharm Assoc, 1989, 7, 81-85.
36. Grases F, March JG, Ramis M and Costa-Bauza A, The influence of Zea mays on urinary risk factors for kidney stones in rats, Phytother Res, 1993, 7, 146-149.
37. Muthukumar A and Selvam R, Effect of depletion of reduced glutathione and its supplementation by glutathione monoester on renal oxalate retention in hyperoxaluria, J Nutr Biochem, 1997, 8, 445-449.
38. Lenin M, Latha LM, Nagraj M and Varalaxmi P, Mitigation of free radical toxicity in hyperoxaluric condition by a novel derivative eicosapentaenoate- Lipoate, Hum Exp Toxicol, 2002, 21, 153-158.
39. Selvam R and Bijikurien T, Restoration of antioxidants in liver by methionine feeding in experimental rat urolithiasis, Indian J Biochem Biophys, 1992, 29, 364-371.
40. Kawada N, Seki S and Kuroki T, Effect of Antioxidants resveratrol, quercetin and N-acetyl cystein, on the functions of cultured rat hepatic stellate cells and kupfer cells, Hepatology, 1998, 27, 1265-1274.
41. Pannala AS, Raza QR, Halliwel B, Singh HS and Rice-Evans CA, Inhibition of peroxynitrite dependent tyrosine nitration by hydroxyl cunamates, nitration or electron donation, Free Radic Biol Med, 1998, 24, 594-606.
42. Ray-Yu Yang, Shou Lin and George Kuo, Content and distribution of flavonoids among 91 edible plant species, Asia Pac J Clin Nutr, 2008, 17, 275-279.